Insider Selling: Malik Fady Ibraham, Cytokinetics Inc [CYTK] EVP Research & Development divested 32,605 shares
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cytokinetics Inc shares valued at $2,422,918 were sold by Malik Fady Ibraham on Apr 09 ’24. At $74.31 per share, Malik Fady Ibraham sold 32,605 shares. The insider’s holdings dropped to 138,567 shares worth approximately $9.28 million […]
CYTK stock rated a Neutral by UBS
Cytokinetics Inc’s filing revealed that its EVP Research & Development Malik Fady Ibraham unloaded Company’s shares for reported $2.42 million on Apr 09 ’24. In the deal valued at $74.31 per share,32,605 shares were sold. As a result of this transaction, Malik Fady Ibraham now holds 138,567 shares worth roughly $9.42 million. Then, Malik Fady […]
Cytokinetics Inc [CYTK] Records 50-Day SMA of $72.63
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Cytokinetics Inc shares valued at $2,422,918 were sold by Malik Fady Ibraham on Apr 09 ’24. At $74.31 per share, Malik Fady Ibraham sold 32,605 shares. The insider’s holdings dropped to 138,567 shares worth […]
Cytokinetics Inc [CYTK] Investment Appeal on the Rise
Cytokinetics Inc’s recent filing unveils that its EVP Research & Development Malik Fady Ibraham unloaded Company’s shares for reported $2.2 million on Mar 05 ’24. In the deal valued at $67.56 per share,32,604 shares were sold. As a result of this transaction, Malik Fady Ibraham now holds 138,973 shares worth roughly $10.31 million. Then, HENDERSON […]
A company insider recently sold 32,604 shares of Cytokinetics Inc [CYTK]. Should You Sale?
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cytokinetics Inc shares valued at $2,202,606 were sold by Malik Fady Ibraham on Mar 05 ’24. At $67.56 per share, Malik Fady Ibraham sold 32,604 shares. The insider’s holdings dropped to 138,973 shares worth approximately $9.61 million […]
CYTK’s latest rating updates from top analysts.
In a filing, Cytokinetics Inc revealed its EVP Research & Development Malik Fady Ibraham unloaded Company’s shares for reported $2.2 million on Mar 05 ’24. In the deal valued at $67.56 per share,32,604 shares were sold. As a result of this transaction, Malik Fady Ibraham now holds 138,973 shares worth roughly $10.15 million. Then, HENDERSON […]
Analysts review Cytokinetics Inc’s rating
Cytokinetics Inc’s recent filing unveils that its EVP Research & Development Malik Fady Ibraham unloaded Company’s shares for reported $2.2 million on Mar 05 ’24. In the deal valued at $67.56 per share,32,604 shares were sold. As a result of this transaction, Malik Fady Ibraham now holds 138,973 shares worth roughly $9.55 million. Then, HENDERSON […]
